Ghost Tree Capital’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Ghost Tree Capital’s Portfolio SIOX Stock Details SIOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-12,500	Closed	-$688K	–	78
2017 Q3	$688K	Sell	12,500 -9,375	-43%	-$1.58M	0.15%	62
2017 Q2	$4.06M	Buy	+21,875	New	+$3.83M	0.84%	44
2016 Q4	–	Sell	-50,000	Closed	-$5.6M	–	99
2016 Q3	$5.6M	Sell	50,000 -21,875	-30%	-$2.63M	0.91%	38
2016 Q2	$7.38M	Buy	+71,875	New	+$7.18M	2.13%	15
2015 Q3	–	Sell	-16,875	Closed	-$2.75M	–	99
2015 Q2	$2.75M	Buy	+16,875	New	+$2.86M	0.89%	46

Other funds holding SIOX

QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

IPL Advisers New York $158M AUM 18.16% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

IPLA

Ice Pond Lane Advisers New York $7.38M AUM 1.66% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ghost Tree Capital's SIOX Position: Q4 2017 in Review

Ghost Tree Capital sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2017, closing a stake of 12,500 shares — an estimated $688K sold.

Ghost Tree Capital first reported a position in SIOX in Q2 2015 and held it in 5 quarters. The position peaked at $7.38M in Q2 2016. 104 funds tracked by Wall St. Rank hold SIOX as of Q4 2017.

Ghost Tree Capital reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
Ghost Tree Capital sold 12,500 Sio Gene Therapies Inc. Common Stock shares in Q4 2017, an estimated $688K.
Ghost Tree Capital first reported a position in Sio Gene Therapies Inc. Common Stock in Q2 2015 and held it in 5 quarters.
Ghost Tree Capital's Sio Gene Therapies Inc. Common Stock position peaked at $7.38M in Q2 2016.
104 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2017.

Based on Ghost Tree Capital's 13F filing for Q4 2017, filed 14 Feb 2018.